VRCA
Verrica Pharmaceuticals Inc.$5.45-0.35 (-6.03%)Prev Close$5.80·MCap$53.9M·P/E—·Vol120.7K·Yield—
▲
Buys (12M)
5
$17.97M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$17.97M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Verrica Pharmaceuticals Inc. (VRCA) has been exclusively buying, with 5 insider purchases totaling $17.97M and 0 insider sales totaling $0.00. The most recent insider transaction was by Kirby John J. (Interim CFO), who purchased $15.0K worth of shares on Nov 25, 2025. Verrica Pharmaceuticals Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $53.9M.
VRCA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Kirby John J. | Interim CFO | Buy | 3,536 | $4.24 | $15.0K | 0 |
| Nov 25, 2025 | Manning Paul B | Director | Buy | 4,126,142 | $4.24 | $17.51M | 0 |
| Nov 25, 2025 | Rieger Jayson | CEO and President | Buy | 94,311 | $4.24 | $400.1K | 0 |
| Nov 25, 2025 | Rosenberg Noah L. | CMO | Buy | 2,357 | $4.24 | $10.0K | 0 |
| Nov 25, 2025 | Zawitz David | Chief Operating Officer | Buy | 10,000 | $4.24 | $42.4K | 0 |
| Mar 14, 2025 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 4,315 | $0.65 | $2.8K | 0 |
| Aug 28, 2024 | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | Sell | 33,702 | $2.61 | $87.8K | 82,107 |
| Aug 28, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | 13,489 | $2.61 | $35.2K | 97,862 |
| Aug 28, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 35,713 | $2.61 | $93.1K | 115,303 |
| Aug 28, 2024 | Kohler Terry | CHIEF FINANCIAL OFFICER | Sell | 29,719 | $2.61 | $77.5K | 52,596 |
| Aug 28, 2024 | White Ted | PRESIDENT AND CEO | Sell | 34,000 | $2.61 | $88.6K | 224,988 |
| Jul 23, 2024 | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | Sell | 25,576 | $7.06 | $180.6K | 106,931 |
| Jul 23, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | 18,507 | $7.06 | $130.7K | 107,836 |
| Jul 23, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 21,740 | $7.06 | $153.5K | 141,577 |
| Jul 23, 2024 | White Ted | PRESIDENT AND CEO | Sell | 32,623 | $7.06 | $230.3K | 250,121 |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 321,616 | $7.17 | $2.31M | 7,099,182 |
| Dec 26, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 504,652 | $6.45 | $3.26M | 6,777,566 |
| Dec 19, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,233,931 | $5.63 | $6.94M | 6,272,914 |
| Nov 16, 2023 | Bonaccorso Joe | Chief Commercial Officer | Sell | 32,846 | $2.94 | $96.7K | 103,658 |
| Nov 16, 2023 | Goldenberg Gary | Chief Medical Officer | Sell | 8,853 | $2.94 | $26.1K | 89,293 |
| Nov 16, 2023 | Hayes Christopher G. | Chief Legal Officer | Sell | 33,699 | $2.94 | $99.2K | 134,784 |
| Nov 16, 2023 | Kohler Terry | Chief Financial Officer | Sell | 28,084 | $2.94 | $82.7K | 44,048 |
| Nov 16, 2023 | White Ted | President and CEO | Sell | 33,699 | $2.94 | $99.2K | 181,648 |
| Jul 25, 2023 | Bonaccorso Joe | Chief Commercial Officer | Sell | 38,262 | $4.83 | $184.8K | 62,738 |
| Jul 25, 2023 | Goldenberg Gary | Chief Medical Officer | Sell | 28,699 | $4.83 | $138.6K | 70,110 |
| Jul 25, 2023 | Hayes Christopher G. | Chief Legal Officer | Sell | 33,789 | $4.83 | $163.2K | 81,925 |
| Jul 25, 2023 | White Ted | President and CEO | Sell | 50,677 | $4.83 | $244.8K | 128,789 |
| Jul 24, 2023 | Manning Paul B | Director | Buy | 200,000 | $5.02 | $1.00M | 7,851,128 |
| Jul 11, 2022 | Hayes Christopher G. | Chief Legal Officer | Buy | 7,500 | $3.40 | $25.5K | 15,714 |
| Jul 5, 2022 | Goldenberg Gary | Chief Medical Officer | Buy | 23,809 | $2.10 | $50.0K | 23,809 |
| Jul 5, 2022 | Hayes Christopher G. | Chief Legal Officer | Buy | 5,714 | $2.10 | $12.0K | 8,214 |
| Jul 5, 2022 | Manning Paul B | Director | Buy | 4,761,904 | $2.10 | $10.00M | 13,651,128 |
| Jul 5, 2022 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,428,571 | $2.10 | $3.00M | 5,038,983 |
| Jul 5, 2022 | Stalfort John A III | Director | Buy | 238,095 | $2.10 | $500.0K | 700,205 |
| Jul 5, 2022 | White Ted | President and CEO | Buy | 23,809 | $2.10 | $50.0K | 29,466 |
| Dec 6, 2021 | Manning Paul B | Director | Buy | 50,000 | $9.36 | $467.9K | 8,149,394 |
| Jun 7, 2021 | DAVIS A BRIAN | Chief Financial Officer | Buy | 5,000 | $9.89 | $49.5K | 12,900 |
| Jun 7, 2021 | Hayes Christopher G. | Chief Legal Officer | Buy | 2,500 | $9.79 | $24.5K | 2,500 |
| Jun 7, 2021 | White Ted | President and CEO | Buy | 4,000 | $9.95 | $39.8K | 21,966 |
| Mar 29, 2021 | Manning Paul B | Director | Buy | 739,830 | $14.75 | $10.91M | 739,830 |
VRCA Insider Buying Activity
The following table shows recent insider purchases of Verrica Pharmaceuticals Inc. (VRCA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Kirby John J. | Interim CFO | Buy | 3,536 | $4.24 | $15.0K | 0 |
| Nov 25, 2025 | Manning Paul B | Director | Buy | 4,126,142 | $4.24 | $17.51M | 0 |
| Nov 25, 2025 | Rieger Jayson | CEO and President | Buy | 94,311 | $4.24 | $400.1K | 0 |
| Nov 25, 2025 | Rosenberg Noah L. | CMO | Buy | 2,357 | $4.24 | $10.0K | 0 |
| Nov 25, 2025 | Zawitz David | Chief Operating Officer | Buy | 10,000 | $4.24 | $42.4K | 0 |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 321,616 | $7.17 | $2.31M | 7,099,182 |
| Dec 26, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 504,652 | $6.45 | $3.26M | 6,777,566 |
| Dec 19, 2023 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,233,931 | $5.63 | $6.94M | 6,272,914 |
| Jul 24, 2023 | Manning Paul B | Director | Buy | 200,000 | $5.02 | $1.00M | 7,851,128 |
| Jul 11, 2022 | Hayes Christopher G. | Chief Legal Officer | Buy | 7,500 | $3.40 | $25.5K | 15,714 |
| Jul 5, 2022 | Goldenberg Gary | Chief Medical Officer | Buy | 23,809 | $2.10 | $50.0K | 23,809 |
| Jul 5, 2022 | Hayes Christopher G. | Chief Legal Officer | Buy | 5,714 | $2.10 | $12.0K | 8,214 |
| Jul 5, 2022 | Manning Paul B | Director | Buy | 4,761,904 | $2.10 | $10.00M | 13,651,128 |
| Jul 5, 2022 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,428,571 | $2.10 | $3.00M | 5,038,983 |
| Jul 5, 2022 | Stalfort John A III | Director | Buy | 238,095 | $2.10 | $500.0K | 700,205 |
| Jul 5, 2022 | White Ted | President and CEO | Buy | 23,809 | $2.10 | $50.0K | 29,466 |
| Dec 6, 2021 | Manning Paul B | Director | Buy | 50,000 | $9.36 | $467.9K | 8,149,394 |
| Jun 7, 2021 | DAVIS A BRIAN | Chief Financial Officer | Buy | 5,000 | $9.89 | $49.5K | 12,900 |
| Jun 7, 2021 | Hayes Christopher G. | Chief Legal Officer | Buy | 2,500 | $9.79 | $24.5K | 2,500 |
| Jun 7, 2021 | White Ted | President and CEO | Buy | 4,000 | $9.95 | $39.8K | 21,966 |
| Mar 29, 2021 | Manning Paul B | Director | Buy | 739,830 | $14.75 | $10.91M | 739,830 |
VRCA Insider Selling Activity
The following table shows recent insider sales of Verrica Pharmaceuticals Inc. (VRCA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 4,315 | $0.65 | $2.8K | 0 |
| Aug 28, 2024 | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | Sell | 33,702 | $2.61 | $87.8K | 82,107 |
| Aug 28, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | 13,489 | $2.61 | $35.2K | 97,862 |
| Aug 28, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 35,713 | $2.61 | $93.1K | 115,303 |
| Aug 28, 2024 | Kohler Terry | CHIEF FINANCIAL OFFICER | Sell | 29,719 | $2.61 | $77.5K | 52,596 |
| Aug 28, 2024 | White Ted | PRESIDENT AND CEO | Sell | 34,000 | $2.61 | $88.6K | 224,988 |
| Jul 23, 2024 | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | Sell | 25,576 | $7.06 | $180.6K | 106,931 |
| Jul 23, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | 18,507 | $7.06 | $130.7K | 107,836 |
| Jul 23, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | 21,740 | $7.06 | $153.5K | 141,577 |
| Jul 23, 2024 | White Ted | PRESIDENT AND CEO | Sell | 32,623 | $7.06 | $230.3K | 250,121 |
| Nov 16, 2023 | Bonaccorso Joe | Chief Commercial Officer | Sell | 32,846 | $2.94 | $96.7K | 103,658 |
| Nov 16, 2023 | Goldenberg Gary | Chief Medical Officer | Sell | 8,853 | $2.94 | $26.1K | 89,293 |
| Nov 16, 2023 | Hayes Christopher G. | Chief Legal Officer | Sell | 33,699 | $2.94 | $99.2K | 134,784 |
| Nov 16, 2023 | Kohler Terry | Chief Financial Officer | Sell | 28,084 | $2.94 | $82.7K | 44,048 |
| Nov 16, 2023 | White Ted | President and CEO | Sell | 33,699 | $2.94 | $99.2K | 181,648 |
| Jul 25, 2023 | Bonaccorso Joe | Chief Commercial Officer | Sell | 38,262 | $4.83 | $184.8K | 62,738 |
| Jul 25, 2023 | Goldenberg Gary | Chief Medical Officer | Sell | 28,699 | $4.83 | $138.6K | 70,110 |
| Jul 25, 2023 | Hayes Christopher G. | Chief Legal Officer | Sell | 33,789 | $4.83 | $163.2K | 81,925 |
| Jul 25, 2023 | White Ted | President and CEO | Sell | 50,677 | $4.83 | $244.8K | 128,789 |
VRCA Insiders
Similar Stocks to VRCA
VRTX
Vertex Pharmaceuticals Incorporated
$455.32-0.63%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$731.17-0.85%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$314.44+1.11%
$42.07B
INSM
Insmed Incorporated
$137.77-4.26%
$30.07B
UTHR
United Therapeutics Corporation
$522.94-0.78%
$23.50B
MRNA
Moderna, Inc.
$50.87-2.94%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.30-1.83%
$20.08B
RPRX
Royalty Pharma plc
$45.45-0.18%
$19.56B